ERBB2 and breast carcinoma: While various endocrine therapies and anti-HER2 therapies +/- chemotherapy regimens can be utilized to combat the Luminal A/B and HER2 + breast cancer subtypes, TNBCs are majorly treated with chemotherapy [12–16].